Impax Small Cap Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Impax Small Cap Fund Investor Class PXSCX
- NAV / 1-Day Return 22.74 / −0.09 %
- Total Assets 961.6M
-
Adj. Expense Ratio
1.160%
- Expense Ratio 1.160%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Small Blend
- Investment Style Small Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 36%
USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:11 AM GMT+0
Morningstar’s Analysis PXSCX
Will PXSCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 32.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Victory Capital Holdings Inc Class A | 5.52 | 47M | Financial Services |
Ligand Pharmaceuticals Inc | 4.68 | 39M | Healthcare |
Acadian Asset Management Inc | 3.65 | 31M | Financial Services |
Neurocrine Biosciences Inc | 3.01 | 25M | Healthcare |
Eastern Bankshares Inc Ordinary Shares | 2.99 | 25M | Financial Services |
Mitek Systems Inc | 2.93 | 25M | Technology |
Arcosa Inc | 2.58 | 22M | Industrials |
Teradata Corp | 2.52 | 21M | Technology |
Pinnacle Financial Partners Inc | 2.50 | 21M | Financial Services |
SI-BONE Inc | 2.39 | 20M | Healthcare |